Okolo AI, Soucie JM, Grosse SD, et al. Population-based surveillance of haemophilia and patient outcomes in Indiana using multiple data sources. Haemophilia. 2019;25:456-462.
Drayton Jackson M, Dunn MW, Storey MA, et al. Increasing optimal coagulation factor dosing in the paediatric emergency department: A quality improvement study. Haemophilia. 2019;25:258-263.
National Hemophilia Foundation. MASAC recommendation concerning guidelines for emergency department management of individuals with hemophilia and other bleeding disorders. Document #257. https://www.hemophilia.org/sites/default/files/document/files/257.pdf. Accessed December 7, 2019.
Srivastava A, Brewer AK, Mauser-Bunschoten EP, et al. WFH guidelines for the management of haemophilia. Haemophilia. 2013;19:e1-e47.
Woods GM, Dunn MW, Dunn AL, et al. Emergencies in hemophilia. Clin Pediatr Emerg. 2018;19:110-121.
Manco-Johnson MJ, Abshire TC, Shapiro AD, et al. Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia. N Engl J Med. 2007;357:535-544.
National Hemophilia Foundation. MASAC recommendation concerning products licensed for the treatment of hemophilia and other bleeding disorders. Medical and Scientific Advisory Council Document #253. https://www.hemophilia.org/sites/default/files/document/files/masac253.pdf. Accessed November 14, 2019.
Di Michele DM, Gibb C, Lefkowitz JM, et al. Severe and moderate haemophilia A and B in US females. Haemophilia. 2014;20:e136-e143.
Oldenburg J, Mahlangu JN, Kim B, et al. Emicizumab prophylaxis in hemophilia A with inhibitors. N Engl J Med. 2017;377:809-818.
Mahlangu J, Oldenburg J, Paz-Priel I, et al. Emicizumab prophylaxis in patients who have hemophilia A without inhibitors. N Engl J Med. 2018;379:811-822.
Singleton T, Kruse-Jarres R, Leissinger C. Emergency department care for patients with hemophilia and von Willebrand disease. J Emerg Med. 2010;39:158-165.

CME / CE

Evaluation and Management of Hemophilia in the Emergency Department

Authors: Amy L. Dunn, MD; Jennifer Maahs, RN-BC, MSN, PNP; Colin G. Kaide, MD; Mohamed Hagahmed, MD; Jessica Copacia, MS, APRN, AC-PNP; Marilyn J. Heine, MD, FACEP, FACP, FCPP (ACEP Course Director)
CME / CE Released: 12/27/2019
THIS ACTIVITY HAS EXPIRED FOR CREDIT
Valid for credit through: 12/26/2020, 11:59 PM EST

Target Audience and Goal Statement

This activity is intended for emergency medicine physicians, hematologists, pediatricians, nurses, and other healthcare professionals who manage patients with hemophilia.

The goal of this activity is to increase understanding of the optimal management of patients with hemophilia who present to the emergency department (ED).

Upon completion of this activity, participants will:

Discuss common complications related to hemophilia
Triage and assess hemophilia patients who present to the emergency department (ED)
Apply latest recommendations for treating hemophilia patients in the emergency department
Prepare systematic approach to work collaboratively in interprofessional team to improve the care for patients with hemophilia who present to the ED

Statement of Support

This activity is supported by independent educational grants from Genentech, Inc., and Novo Nordisk Inc.

Faculty

Amy Dunn, MD

Professor of Pediatrics
Director of Pediatric Hematology
Nationwide Children’s Hospital
The Ohio State University
Columbus, Ohio

Disclosures

Disclosure: Amy L. Dunn, MD, has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: CSL Behring; Genentech, Inc.; Pfizer Inc.; uniQure
Received grants for clinical research from: Baxalta; BioMarin Pharmaceutical; Biogen; Swedish Orphan Biovitrum; Takeda Pharmaceutical Company

Mohamed Hagahmed, MD

Assistant Clinical Professor
Department of Emergency Medicine
UT Health San Antonio
San Antonio, Texas

Disclosures

Disclosure: Mohammed Hagahmed, MD, has disclosed no relevant financial relationships.

Colin G Kaide, MD

Associate Professor of Emergency Medicine
Specialist in Hyperbaric Medicine
Department of Emergency Medicine
Wexner Medical Center at The Ohio State University
Columbus, Ohio

Disclosures

Disclosure: Colin G. Kaide, MD, has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Portola Pharmaceuticals
Served as a speaker or a member of a speakers bureau for: Portola Pharmaceuticals
Owns stock, stock options, or bonds from: Callibra, Inc.

Jennifer Maahs

Hemophilia Nurse Practitioner
Director of Bleeding Disorder Care and Coordination
Indiana Hemophilia & Thrombosis Center
Indianapolis, Indiana

Disclosures

Disclosure: Jennifer Maahs, RN-BC, MSN, PNP, has disclosed the following relevant financial relationships:
Served as a speaker or a member of a speakers bureau for: Genentech Advisory Board, Speakers Bureau; Novo Nordisk, Speakers Bureau; Sanofi, Speakers Bureau, Advisory Board; Takeda Advisory Board

Healthcare Perspective

Jessica Copacia, MS, APRN, AC-PNP

Emergency Medicine
Nationwide Children’s Hospital
Columbus, Ohio

Disclosures

Disclosure: Jessica Copacia, MS, APRN, AC-PNP, has disclosed no relevant financial relationships.

Editor

Charlotte Warren

Senior Medical Education Director, Medscape, LLC

Disclosures

Disclosure: Charlotte Warren has disclosed no relevant financial relationships.

NHF Course Reviewer

Neil Frick, MS

Senior Vice President of Medical Programs and Information
National Hemophilia Foundation
New York, New York

Disclosures

Disclosure: Neil Frick, MS, has disclosed no relevant financial relationships.

ACEP Course Director

Marilyn J. Heine, MD, FACEP, FACP, FCPP

Clinical Assistant Professor of Medicine
Drexel University College of Medicine
Abington, Pennsylvania

Disclosures

Disclosure: Marilyn J. Heine, MD, has disclosed no relevant financial relationships.

ACEP

Riane Gay, MPA

Senior Manager, Grants & Development
American College of Emergency Physicians
Irving, Texas

Disclosures

Disclosure: Riane Gay, MPA, has disclosed no relevant financial relationships.

Sam Shahid, MD, MBBS, MPH

Practice Management Manager
American College of Emergency Physicians
Irving, Texas

Disclosures

Disclosure: Sam Shahid, MD, MBBS, MPH, has disclosed no relevant financial relationships.

Lori Vega

Chief Development Officer
American College of Emergency Physicians
Irving, Texas

Disclosures

Disclosure: Lori Vega has disclosed no relevant financial relationships.

CE Reviewer / Nurse Planner

Hazel Dennison, DNP, RN, FNP, CPHQ, CNE

Associate Director, Accreditation and Compliance, Medscape, LLC

Disclosures

Disclosure: Hazel Dennison, DNP, RN, FNP, CPHQ, CNE, has disclosed no relevant financial relationships.

Medscape

Haleh Kadkhoda, MS

Medscape Education, Strategic Partnerships

Disclosures

Disclosure: Haleh Kadkhoda, MS, has disclosed no relevant financial relationships.

Medscape, LLC staff have disclosed that they have no relevant financial relationships.

Peer Reviewer
This activity has been peer reviewed and the reviewer has disclosed no relevant financial relationships.

Accreditation Statements

Developed through a partnership between Medscape and American College of Emergency Physicians (ACEP) and National Hemophilia Foundation.

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American College of Emergency Physicians, Medscape, and National Hemophilia Foundation.

The American College of Emergency Physicians is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

For Physicians

The American College of Emergency Physicians designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s) ^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Contact This Provider

For Nurses

Awarded 0.50 contact hour(s) of continuing nursing education for RNs and APNs; 0 contact hours are in the area of pharmacology.

This activity was planned by and for the healthcare team, and learners will receive 0.50 Interprofessional Continuing Education (IPCE) credit for learning and change.

Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]

Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 75% on the post-test.

Follow these steps to earn CME/CE credit*:

Read the target audience, learning objectives, and author disclosures.
Study the educational content online or printed out.
Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

From Medscape Education Emergency Medicine

CME / CE

Evaluation and Management of Hemophilia in the Emergency Department

Authors: Amy L. Dunn, MD; Jennifer Maahs, RN-BC, MSN, PNP; Colin G. Kaide, MD; Mohamed Hagahmed, MD; Jessica Copacia, MS, APRN, AC-PNP; Marilyn J. Heine, MD, FACEP, FACP, FCPP (ACEP Course Director)Faculty and Disclosures

THIS ACTIVITY HAS EXPIRED FOR CREDIT

CME / CE Released: 12/27/2019

Valid for credit through: 12/26/2020, 11:59 PM EST

processing....

Educational Impact Challenge

The goal of this activity is to increase understanding of the optimal management of patients with hemophilia who present to the emergency department (ED).

Before you begin this activity, please assess your clinical knowledge by completing this brief survey. Answering these questions again after the activity will allow you to see what you learned and to compare your answers with those of your peers.

Page 1 of 5

CME / CE Information Download Slides

Activity Transcript

PDF Downloads

Print
Like Tweet

Disclaimer

The educational activity presented above may involve simulated, case-based scenarios. The patients depicted in these scenarios are fictitious and no association with any actual patient, whether living or deceased, is intended or should be inferred. The material presented here does not necessarily reflect the views of Medscape, LLC, or any individuals or commercial entities that support companies that support educational programming on medscape.org. These materials may include discussion of therapeutic products that have not been approved by the US Food and Drug Administration, off-label uses of approved products, or data that were presented in abstract form. These data should be considered preliminary until published in a peer-reviewed journal. Readers should verify all information and data before treating patients or employing any therapies described in this or any educational activity. A qualified healthcare professional should be consulted before using any therapeutic product discussed herein.

References

Faculty and Disclosures

Faculty

Amy Dunn, MD

Mohamed Hagahmed, MD

Colin G Kaide, MD

Jennifer Maahs

Healthcare Perspective

Jessica Copacia, MS, APRN, AC-PNP

Editor

Charlotte Warren

NHF Course Reviewer

Neil Frick, MS

ACEP Course Director

Marilyn J. Heine, MD, FACEP, FACP, FCPP

ACEP

Riane Gay, MPA

Sam Shahid, MD, MBBS, MPH

Lori Vega

CE Reviewer / Nurse Planner

Hazel Dennison, DNP, RN, FNP, CPHQ, CNE

Medscape

Haleh Kadkhoda, MS

CME / CE

Evaluation and Management of Hemophilia in the Emergency Department

Target Audience and Goal Statement

Faculty

Amy Dunn, MD

Mohamed Hagahmed, MD

Colin G Kaide, MD

Jennifer Maahs

Healthcare Perspective

Jessica Copacia, MS, APRN, AC-PNP

Editor

Charlotte Warren

NHF Course Reviewer

Neil Frick, MS

ACEP Course Director

Marilyn J. Heine, MD, FACEP, FACP, FCPP

ACEP

Riane Gay, MPA

Sam Shahid, MD, MBBS, MPH

Lori Vega

CE Reviewer / Nurse Planner

Hazel Dennison, DNP, RN, FNP, CPHQ, CNE

Medscape

Haleh Kadkhoda, MS

Accreditation Statements

For Physicians

For Nurses

Instructions for Participation and Credit

Evaluation and Management of Hemophilia in the Emergency Department

Educational Impact Challenge

PDF Downloads